Can naming your feelings boost resilience in young cancer survivors?
NCT ID NCT07200388
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at how well young and middle-aged colorectal cancer survivors can identify and describe their specific emotions—a skill called emotional granularity—and whether that helps them build resilience. Researchers surveyed 242 survivors online and interviewed some in depth. No treatments were tested; the goal was simply to understand the connection between emotions and coping.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could point toward new psychological support strategies to help cancer survivors cope better after treatment.
- What could go wrong
- This is an observational study, not a treatment trial. It only measures emotions and resilience, so it cannot directly improve health or survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER (CRC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kunshan First People's Hospital Affiliated to Jiangsu University
Suzhou, Jiangsu, 215000, China
-
The First Affiliated Hospital of Soochow University
Suzhu, Jiangsu, 215000, China
-
The Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Why are more younger adults getting colorectal cancer? a national study digs into the data
- New drug combo aims to boost response in Hard-to-Treat colorectal cancer
- First-in-Class cancer drug targets Hard-to-Treat tumors
- New pill targets Hard-to-Treat cancers with a specific gene mutation
- AI eye on cancer: robot helps spot hidden polyps
- New hope for Hard-to-Treat colorectal cancer? drug combo trial launches